AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 94 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q3 2015. The put-call ratio across all filers is 2.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,318,000 | -45.0% | 835,270 | +1.2% | 0.00% | -50.0% |
| Q4 2015 | $7,857,000 | +7.5% | 825,304 | -6.9% | 0.00% | 0.0% |
| Q3 2015 | $7,308,000 | -46.4% | 886,901 | +5.6% | 0.00% | -33.3% |
| Q2 2015 | $13,635,000 | -36.8% | 839,620 | +57.8% | 0.00% | -40.0% |
| Q1 2015 | $21,558,000 | -12.3% | 532,023 | +16.9% | 0.01% | -16.7% |
| Q4 2014 | $24,576,000 | +322.9% | 455,108 | +167.8% | 0.01% | +200.0% |
| Q3 2014 | $5,811,000 | – | 169,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|